November 13th 2024
Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.
Should Pharmaceutical Companies be Putting their Heads in the Cloud?
December 1st 2014Despite concerns over regulation and data protection, cloud computing is entering the world of pharmaceuticals. There are good reasons why the cloud might suit pharmaceutical companies-greater efficiency, lower costs, the ability to take data in the public domain and mesh it with private data sets-all good reasons to embrace the cloud. But, assuming that the regulatory concerns can be overcome, is the cloud what it appears to be?
Data Management in Manufacturing
May 2nd 2014Pharmaceutical Technology spoke with Gloria Gadea-Lopez, associate director of Shire, and Martin Dittmer, PharmaSuite product manager at Rockwell Automation, about how manufacturing execution systems (MES) can improve productivity and the current challenges faced by companies implementing MES systems.
Incorporating Process Analytical Technology Data into Process Control
March 20th 2013Process analytical technology (PAT) is being successfully used to improve understanding and optimize pharmaceutical unit operations, but greater value can be obtained by integrating PAT with overall process control of a continuous manufacturing system. Pharmaceutical Technology spoke with Ivo Backx, manager of business and project development for the pharmaceutical industry at Siemens Industry Automation Division, to gain insight on the issues involved.
Improving Intelligent Device Management
October 17th 2012Strategic management of intelligent devices is important in any processing field, and a new standards committee at the International Society of Automation aims to provide direction so that manufacturers can better utilize the devices' capabilities.
Is Pharma Getting the Best out of Social Media?
June 1st 2012With social media receiving increased focus as the pharma industry strives to make the most of new communication technologies, we speak with Cognizant's Bhaskar Sambasivan to find out where pharma is when it comes to social media implementation and what more should be being done.
Addressing Elemental Impurity Limits with ICP–OES and ICP–MS
November 1st 2011The US Pharmacopeia (USP) proposes to lower the maximum permissible limits of trace elements in pharmaceuticals and recommends that impurities be measured through automated instrumentation-based methods. The proposed regulations specify inductively coupled plasma–mass spectrometry (ICP–MS) and inductively coupled plasma–optical emission spectrometry (ICP–OES) as the techniques of choice. This article discusses the benefits of ICP–MS and ICP–OES for the accurate detection of trace elements in pharmaceutical products, in compliance with the proposed USP chapters.